Yi‐Chun Liu

3.4k total citations
86 papers, 1.8k citations indexed

About

Yi‐Chun Liu is a scholar working on Epidemiology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Yi‐Chun Liu has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 22 papers in Surgery and 22 papers in Otorhinolaryngology. Recurrent topics in Yi‐Chun Liu's work include Head and Neck Cancer Studies (21 papers), Burkholderia infections and melioidosis (12 papers) and Head and Neck Surgical Oncology (8 papers). Yi‐Chun Liu is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Burkholderia infections and melioidosis (12 papers) and Head and Neck Surgical Oncology (8 papers). Yi‐Chun Liu collaborates with scholars based in Taiwan, Singapore and China. Yi‐Chun Liu's co-authors include Eng Eong Ooi, Gek-Yen Gladys Tan, Chih‐Wen Twu, Jin‐Ching Lin, Yunn‐Hwen Gan, Po‐Ju Lin, Rong‐San Jiang, Dongling Wang, Shin‐Ru Shih and Yu‐Nong Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yi‐Chun Liu

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Chun Liu Taiwan 24 627 330 306 293 291 86 1.8k
Paola Cattani Italy 26 671 1.1× 501 1.5× 110 0.4× 509 1.7× 343 1.2× 98 2.0k
Jean‐San Chia Taiwan 29 516 0.8× 198 0.6× 67 0.2× 221 0.8× 481 1.7× 75 1.9k
Michela Sali Italy 24 839 1.3× 111 0.3× 120 0.4× 1.1k 3.6× 391 1.3× 92 1.9k
Marc Baay Belgium 28 1.1k 1.7× 934 2.8× 100 0.3× 218 0.7× 640 2.2× 89 2.6k
Rajesh V. Lalla United States 20 243 0.4× 320 1.0× 390 1.3× 460 1.6× 697 2.4× 51 2.0k
Lifang Zhang China 23 434 0.7× 384 1.2× 44 0.1× 258 0.9× 707 2.4× 113 1.7k
Mei San Tang United States 20 235 0.4× 163 0.5× 84 0.3× 651 2.2× 837 2.9× 57 2.1k
Jung Joo Hong South Korea 23 544 0.9× 131 0.4× 51 0.2× 331 1.1× 218 0.7× 84 1.7k
Fulvia Pimpinelli Italy 23 367 0.6× 198 0.6× 33 0.1× 310 1.1× 289 1.0× 69 1.5k
W. H. Hoffmann Germany 24 142 0.2× 161 0.5× 69 0.2× 776 2.6× 377 1.3× 89 1.8k

Countries citing papers authored by Yi‐Chun Liu

Since Specialization
Citations

This map shows the geographic impact of Yi‐Chun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Chun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Chun Liu more than expected).

Fields of papers citing papers by Yi‐Chun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Chun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Chun Liu. The network helps show where Yi‐Chun Liu may publish in the future.

Co-authorship network of co-authors of Yi‐Chun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Chun Liu. A scholar is included among the top collaborators of Yi‐Chun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Chun Liu. Yi‐Chun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Haolin, Haodong Liu, Jiayong Liu, et al.. (2025). [Artemin promotes proliferation and invasion of malignant peripheral nerve sheath tumor cells through the PI3K/Akt pathway].. PubMed. 47(2). 149–159.
3.
Twu, Chih‐Wen, Po‐Ju Lin, Yi‐Chun Liu, et al.. (2025). Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact. Oral Oncology. 167. 107456–107456.
4.
Magee, Lacey C., et al.. (2025). Speech Delay and Hearing Rehabilitation Disparities in Children With Hearing Loss. Otolaryngology. 172(6). 2098–2104. 1 indexed citations
6.
Wu, Chia‐Chao, Li‐Ting Kao, Yi‐Chun Liu, et al.. (2024). Sleep Duration and Kidney Function – Does Weekend Sleep Matter?. Nature and Science of Sleep. Volume 16. 85–97. 2 indexed citations
7.
Liu, Yi‐Chun, Pingping Xue, Yinghua Qi, et al.. (2024). Cold scissors ploughing technique versus electrosurgical excision for hysteroscopic adhesiolysis: a multicenter randomized controlled trial. International Journal of Surgery. 111(2). 2002–2009.
9.
Ho, Alan L., Douglas R. Adkins, George J. Hanna, et al.. (2023). LBA47 A phase II study evaluating tipifarnib in mHRAS, recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) (AIM-HN study). Annals of Oncology. 34. S1286–S1287. 4 indexed citations
10.
Zhou, Hua, et al.. (2023). Dietary puerarin supplementation improves immune function in the small intestines of oxidized oil‐challenged broilers. Animal Science Journal. 94(1). e13895–e13895. 5 indexed citations
11.
Zong, Jing, Po‐Ju Lin, Hsiao‐Hui Tsou, et al.. (2023). Comparison the acute toxicity of two different induction chemotherapy schedules with cisplatin and fluorouracil in nasopharyngeal carcinoma patients. Radiotherapy and Oncology. 184. 109699–109699. 2 indexed citations
12.
Chen, Chien‐Chih, et al.. (2022). Peri-Neural Invasion Is an Important Prognostic Factor of T2N0 Oral Cancer. Medicina. 58(12). 1809–1809. 6 indexed citations
13.
Wang, Chen‐Chi, Wen‐Jiun Lin, Yi‐Chun Liu, et al.. (2021). Transoral Robotic Surgery for Pharyngeal and Laryngeal Cancers—A Prospective Medium-Term Study. Journal of Clinical Medicine. 10(5). 967–967. 4 indexed citations
14.
Huang, Chung‐Guei, Kuo-Ming Lee, Peng-Nien Huang, et al.. (2020). Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19. Journal of Clinical Microbiology. 58(8). 96 indexed citations
15.
Gong, Yu‐Nong, Kuo‐Chien Tsao, Chung‐Guei Huang, et al.. (2020). SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East. Emerging Microbes & Infections. 9(1). 1457–1466. 83 indexed citations
16.
Mukerji, Shraddha S., et al.. (2020). Pediatric otolaryngology workflow changes in a community hospital setting to decrease exposure to novel coronavirus. International Journal of Pediatric Otorhinolaryngology. 136. 110169–110169. 6 indexed citations
17.
Lan, Ming‐Ying, Hsiao‐Hui Tsou, Chih‐Wen Twu, et al.. (2020). Survival impacts of different nodal characteristics and T-classification in N3 nasopharyngeal carcinoma patients. Oral Oncology. 108. 104820–104820. 9 indexed citations
18.
Twu, Chih‐Wen, Wenyi Wang, Kai-Li Liang, et al.. (2014). Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid. International Journal of Radiation Oncology*Biology*Physics. 89(1). 21–29. 79 indexed citations
19.
Liu, Yi‐Chun, et al.. (2010). Endovascular Revascularization of Chronically Thrombosed Arteriovenous Fistulas and Grafts for Hemodialysis: A Retrospective Study in 15 Patients With 18 Access Sites. CardioVascular and Interventional Radiology. 34(2). 319–330. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026